11/07/23 – The Washington Post – AI Tools are Keeping Hospital Patients Alive
In a recent Washington Post article, Leana S. Wen highlights the transformative impact of AI tools in healthcare, particularly in improving patient outcomes. The piece showcases Kaiser Permanente’s success in deploying an AI tool to identify early signs of patient deterioration in hospitals, a task traditionally reliant on clinician vigilance.
This AI system integrates various data points like vital signs and lab tests to alert healthcare teams proactively, helping in the early intervention of potential health crises. The results speak for themselves: a significant reduction in mortality rates. The article also notes the effective use of AI in other hospitals, such as Johns Hopkins, for early sepsis detection.
While Bayesian’s product is referenced in the discussion, the focus remains on the broader benefits and potentials of AI in healthcare.
LINKS
Read the Washington Post article
Read more about Bayesian Health’s approach to Adaptive AI
*Adams, Henry, Saria et al. Nature Medicine, 2022;
*Henry, Adams, Saria et al., Nature Medicine, 2022
10/09/23 – Med City News – How Can LLMs Be Deployed Safely in Healthcare?
Healthcare, like most other industries, has been experimenting with the use of large language models (LLMs) over the past year to streamline things like patient communication, clinical documentation and prior authorization.
While there has certainly been a great deal of hype recently surrounding LLMs and other forms of generative AI, there has also been a lot of skepticism. When it comes to an industry like healthcare, where one small technology failure could be the difference between life and death, many stakeholders are concerned about how to mitigate the risks associated with novel LLMs entering the field.
LINKS
Read the Med City News article
Read more about Bayesian Health’s approach to Adaptive AI
*Adams, Henry, Saria et al. Nature Medicine, 2022;
*Henry, Adams, Saria et al., Nature Medicine, 2022
09/21/23 – A Pioneering Code of Conduct for AI in Healthcare Unveiled by National Academy of Medicine
As a pioneer in the realm of clinical AI, Bayesian Health is both invigorated and deeply aligned with a recent multi-phased initiative spearheaded by the National Academy of Medicine (NAM) Leadership Consortium. With Dr Suchi Saria (Bayesian Health’s CEO) serving as a founding member of the steering committee, this ambitious project aims to establish an Artificial Intelligence Code of Conduct (AICC) for the healthcare sector. Far more than a mere initiative, the AICC serves as a guiding framework that resonates with Bayesian’s unwavering commitment to efficacy and responsible AI use. This endeavor underscores the pivotal role that Bayesian approaches are playing in setting the standard for accurate, safe, reliable, and ethical AI applications in healthcare.
About NAM Leadership Consortium
The National Academy of Medicine (NAM) Leadership Consortium stands as a trusted platform and cornerstone for interdisciplinary dialogue, uniting national leaders across diverse sectors. With a focus on aligning science, informatics, incentives, and culture, the Consortium is committed to fostering a healthcare system that is both innovative and continuously learning. It serves as a linchpin in streamlining the various components essential for improving healthcare outcomes for all, truly embodying the ideal of crafting a healthcare system that benefits everyone.
The Imperative for AICC
With Dr Suchi Saria helping to lead the steering committee, the Artificial Intelligence Code of Conduct (AICC) stands as a timely and imperative answer to the rapid expansion of AI technologies in healthcare. Addressing the pressing need for a cohesive set of best practices and ethical guidelines, the AICC’s two-fold vision aims to harmonize existing ethical principles while pinpointing gaps. In doing so, it seeks to establish a universally respected Code of Conduct that not only serves as a starting point but also as a yardstick for ongoing refinement, testing, validation, and improvement in the ever-evolving landscape of healthcare AI.
AICC Vision
The project aims to catalyze collective action to harness the potential of AI in transforming healthcare delivery and advancing health research, all while upholding high standards of ethics, equity, privacy, and security.
Timeline and Governance
Scheduled to last for three years, the AICC project has a roadmap that includes steering committee meetings, webinars, and final hybrid discussions. The steering committee, composed of thought leaders in multiple fields, will guide the project to ensure it meets its intended aims and earns broad stakeholder support.
Comprehensive Outputs
Among its key deliverables, AICC plans to offer a harmonized Code of Conduct, a comprehensive landscape assessment, a systematic review of guidelines, and a final special publication outlining the Code of Conduct framework for deployment in the healthcare system.
Global Reach
While primarily based on U.S. experience, the initiative intends to be informed by international efforts, making it globally relevant.
Synergistic Reinforcement
NAM is also focused on aligning its work with other initiatives in the field, reinforcing and being informed by other projects to ensure the broad adoption of the Code.
Why Bayesian Health is Intrinsically Involved
For Bayesian Health, the AICC initiative serves as a vital framework that aligns seamlessly with our core values and ambitions, particularly under the strategic guidance of Dr Suchi Saria on the steering committee. Deeply invested in ethical and effective clinical AI, we see the AICC as an essential guide to fine-tuning our practices in concert with broader industry standards.
With backing from various foundations and a commitment to include a diverse set of stakeholders, the project promises to have profound implications for the future of healthcare. Stay engaged with us as we actively participate in this pivotal initiative, shaping and anticipating the transformative impact it will have on making AI a reliable and ethical force in healthcare.
Learn More About the NAM Leadership Consortium
09/12/23 – Recognizing Sepsis Awareness Month 2023: Every Second Counts
September is Sepsis Awareness Month, a critical period for shedding light on a condition that remains the leading cause of hospital deaths in the United States. Initiated by the Sepsis Alliance in 2011, this annual awareness campaign brings together individuals, healthcare professionals across various disciplines, and organizations large and small to amplify the urgency of understanding and combating sepsis.
The Staggering Statistics
Sepsis is a severe and often fatal response to infection, affecting a staggering 1.7 million people and causing the death of 350,000 adults in the U.S. each year. What’s more alarming is that research indicates up to 80% of sepsis-related deaths could potentially be prevented with swift diagnosis and treatment. For every hour that treatment is delayed, the risk of mortality skyrockets by approximately 8%. These numbers underline the imperative nature of education and awareness about sepsis.
At the Core of Bayesian Health’s Mission
Early detection and timely intervention are not just statistical factors; they lie at the very heart of Bayesian Health’s mission. Our commitment to driving efficacy in clinical AI directly aligns with the pressing need for rapid evaluation and treatment of sepsis. By developing tools that empower healthcare providers to diagnose sepsis early, we’re not just innovating; we’re striving to save lives.
Act Now: Resources for Awareness
Our team at Bayesian Health advocates for effective and immediate action to raise sepsis awareness. We strongly recommend taking advantage of the following resources to escalate public understanding of sepsis in your community:
- Sepsis Alliance – Sepsis Awareness Month Toolkit: This comprehensive guide provides in-depth information and ideas for promoting awareness. Download it here.
- The National Association of County Health Officials: They offer a variety of materials and educational pieces on how you can get ahead of sepsis. Visit their website for more information.
Awareness is the first step towards a significant impact. This Sepsis Awareness Month, let’s unite to disseminate knowledge, drive timely interventions, and ultimately, save lives.
Spread the word, because when it comes to sepsis, every second counts.
06/22/23 – Future Medicine – AI Hub – Digital Automation Platforms in Medicine
In this illuminating article written by Neri Cohen, MD PhD Chief Medical Informatics Officer at Bayesian Health, you’ll learn about the transformative impact of digital automation platforms on patient engagement and clinical outcomes.
Dr. Cohen dives into Bayesian Health’s groundbreaking AI platform, which empowers front-line clinicians by translating complex data sets into actionable insights. Developed in collaboration with Johns Hopkins, the platform has already demonstrated an 18.2% decrease in sepsis patient mortality rates and earned FDA designation as a Breakthrough Medical Device. With an adoption rate of 89% among clinicians, Bayesian’s platform is more than a technological marvel; it’s a tool clinicians trust to make data-backed decisions quickly. Dive deeper into the intersection of AI and healthcare, and explore how Bayesian Health is setting new industry standards for patient care.
LINKS
Read the Future Medicine AI Hub Article
Read more about Bayesian Health’s approach to Adaptive AI
*Adams, Henry, Saria et al. Nature Medicine, 2022;
*Henry, Adams, Saria et al., Nature Medicine, 2022
05/05/23 – Stat – 4 ways the health care system should shift its thinking on AI, according to experts
Artificial intelligence (AI) has been making waves in various industries, and healthcare is no exception. As the potential of AI continues to unfold, experts have gathered at the recent 2023 STAT Breakthrough Summit to discuss its transformative impact on the healthcare system. Prominent figures in AI/ML: Nigam Shah, Suchi Saria, and Connor Landgraf shared their invaluable insights, shedding light on the four crucial ways in which the healthcare industry should shift its thinking regarding AI.
Amidst the increasing adoption of AI technologies, even the renowned “Godfather of AI,” Geoffrey Hinton, expressed concerns about the overwhelming power wielded by this disruptive technology. Recent months have witnessed a frenzy of efforts to harness AI in diverse sectors, and healthcare has been at the forefront of these groundbreaking endeavors.
As the boundaries of what is possible continue to be pushed, it becomes imperative for healthcare professionals, policymakers, and stakeholders to reflect on the optimal utilization of AI. This article explores the key takeaways from the discussions at the STAT Breakthrough Summit, offering insights into how the healthcare system should approach AI with a renewed mindset.
Read more about the four fundamental shifts in thinking that experts suggest are necessary for AI to truly revolutionize healthcare. By embracing these transformative concepts, the healthcare industry has the potential to unlock unprecedented advancements and redefine the standards of patient care.
LINKS
Read more about Bayesian Health’s approach to Adaptive AI
*Adams, Henry, Saria et al. Nature Medicine, 2022;
*Henry, Adams, Saria et al., Nature Medicine, 2022
03/28/23 – Stat – As AI promises to revolutionize medical note-taking, concerns mount about accuracy and harm
Fantastic article from Stat, featuring Suchi Saria, PhD exploring the nuance of clinical AI, workflow orchestration, augmentation and other “sticky” issues swirling around artificial intelligence and machine learning.
LINKS
Read more about Bayesian Health’s approach to Adaptive AI
*Adams, Henry, Saria et al. Nature Medicine, 2022;
*Henry, Adams, Saria et al., Nature Medicine, 2022
o3/05/23 –Reducing Variability of Care with Bayesian’s AI Platform
Inconsistent and variable care delivery can lead to negative consequences for hospitals, patients, and payers. Bayesian’s AI platform is designed to help reduce variability in care, improve clinical outcomes, and enhance overall patient satisfaction.
Defining Variability
Variability of care refers to the differences in the way patients are treated and the outcomes they receive based on a wide array of factors such as demography, what hospital they have access to and the care practices employed in their treatment. There are many factors contributing to variability, including lack of evidence-based protocols and fragmented care delivery systems.
The Impact of Variable Care Practices
Variability of care can lead to unequal access to care, inconsistent quality of care, and higher costs for patients, hospitals and payers. These can affect patient satisfaction and create a lack of trust in the healthcare system. Payers also face financial consequences from variability in care, as they may have to cover the cost of additional treatments, longer hospital stays, or readmissions.
How Bayesian’s AI Platform Addresses Variability
Bayesian’s AI platform is designed to address variability in care by providing clinicians with real-time insights and personalized treatment recommendations. The platform uses an adaptive, modular framework that considers a patient’s unique physiology, clinical protocol, provider workflow, and hospital operations. This approach helps clinicians make more informed decisions and reduces the likelihood of variability in care delivery for a wide range of critical condition areas such as sepsis, all-cause deterioration, pressure injuries, and transitions of care, just to name a few.
Practical Uses of Bayesian’s Clinical AI to Standardize Care Practices:
- Bayesian’s AI platform can be tailored to different clinical settings and hospital needs, providing a personalized approach to care.
- The multi-modal platform identifies patterns and trends in patient data that traditional practices/methods may miss.
- Bayesian provides access to evidence-based guidelines and best practices, leading to better treatment decisions and outcomes.
- By automating certain tasks, the platform reduces the time it takes to provide care, improving patient outcomes and reducing costs associated with unnecessary procedures and extended hospital stays.
Our Unique Approach
Unlike previously studied models, Bayesian’s approach is clinically grounded, thinking like a clinician. Clinicians use the platform as an extra set of eyes and ears, making it an effective tool in improving the overall quality of care. The platform uses Bayesian statistical models to analyze patient data, such as medical history, lab results, and vital signs. These models allow clinicians to identify potential risks and predict patient outcomes based on data from similar patients. The platform also provides real-time feedback to clinicians on their treatment plans, alerting them to any potential issues or opportunities for improvement.
Benefits of Reducing Variability
Variability in care can have negative consequences for hospitals, patients, and payers. However, with Bayesian’s AI platform, clinicians can have access to real-time insights and personalized treatment recommendations that can help reduce variability in care delivery. By using Bayesian’s AI platform, hospitals can improve clinical outcomes, enhance patient satisfaction, and reduce costs associated with longer hospital stays or readmissions.
02/28/23 The Wall Street Journal –How Doctors Use AI to Help Diagnose Patients
Thrilled to see this thoughtful discussion in the The Wall Street Journal on the important work that Bayesian Health is doing with our incredible health system partners like LifeBridge Health.
Bayesian’s platform serves as a colleague / co-pilot for doctors and nurses. It empowers clinicians with real-time care signals to manage outcomes and cost while streamlining workflows to save time.
LifeBridge clinicians are forging the path forward for what great care looks like:
- where we don’t miss any critical moments for patients,
- where we can be proactive and not reactive about patient care, and
- where we support clinicians with helpful tools to make their lives easier
We’ve already been able to see improvement in early recognition rates, reduction in treatment delays, significant reductions in length of stay, reduction in alarm fatigue and financial gain conservatively projected to the tune of ~$2Mi+ per 200 beds! And we’ve begun to expand in areas beyond sepsis!*
LINKS
Read the Wall Street Journal article
Read more about Bayesian Health’s approach to Adaptive AI